title: Omega-3 fatty acids are more beneficial in the depressive phase than in the manic phase in patients with bipolar I disorder.
authors.forename: Chih-Chiang
authors.initials: CC
authors.lastname: Chiu
authors.forename: Shih-Yi
authors.initials: SY
authors.lastname: Huang
authors.forename: Chiao-Chicy
authors.initials: CC
authors.lastname: Chen
authors.forename: Kuan-Pin
authors.initials: KP
authors.lastname: Su
mesh_terms: D000208:Acute Disease; D000927:Anticonvulsants / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D010919:Placebos; D011569:Psychiatric Status Rating Scales / Q000706:statistics & numerical data; D016896:Treatment Outcome; D014635:Valproic Acid / Q000627:therapeutic use
chemical_list: D000927:Anticonvulsants; D015525:Fatty Acids, Omega-3; D010919:Placebos; D014635:Valproic Acid